Crossmark

Development and evaluation of hyaluronic acid-coated chitosan nanoparticles for improved delivery of sorafenib tosylate in the treatment of hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1007/s12668-025-01821-w

Published Online: 2025-01-25

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sreelaya, Putrevu https://orcid.org/0000-0002-4692-8248
Bhattacharya, Sankha https://orcid.org/0000-0002-0771-9582
Bhirud, Darshan https://orcid.org/0009-0002-6752-9729
Sharma, Mayank https://orcid.org/0000-0003-3215-9545
Maheshwari, Rahul https://orcid.org/0000-0001-6645-9461
License Information

Text and Data Mining valid from 2025-01-25

Version of Record valid from 2025-01-25
More Information

Article History

Accepted: 15 January 2025

First Online: 25 January 2025

Declarations

:

: The authors declare no competing interests.

: None.

: None.

Document is current

Any future updates will be listed below